Activity of the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate in a Xenograft Model of AIDS-Associated Kaposi's Sarcoma

Author： Rojiani Amyn M. Li Lingyun Rise Leroy Siemann Dietmar W.

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.41, Iss.1, 2002-02, pp. : 98-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi's Sarcoma

By Li Lingyun Rojiani Amyn M. Siemann Dietmar W.

Acta Oncologica, Vol. 41, Iss. 1, 2002-02 ,pp. : 91-97

Informa Healthcare

Access to resources Recommend Favorite

Combretastatin A4 phosphate: a novel vascular disrupting agent

By Nagaiah Govardhanan Remick Scot C

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1219-1228

Future Medicine

Access to resources Recommend Favorite

The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization

By Hokland S. L. Horsman M. R.

International Journal of Hyperthermia, Vol. 23, Iss. 7, 2007-01 ,pp. : 599-606

Informa Healthcare

Access to resources Recommend Favorite

Electron Microscopy Reveals Fungal Cells Within Tumor Tissue from Two African Patients with AIDS-associated Kaposi Sarcoma

By Marquart Karl-Horst

Ultrastructural Pathology, Vol. 30, Iss. 3, 2006-07 ,pp. : 187-192

Informa Healthcare

Access to resources Recommend Favorite

Graduated Systemic Treatment of AIDS-Associated Kaposi Sarcoma: In the Era of Highly Active Antiretroviral Therapy

By Hengge Ulrich R.

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 133-149

Adis International

Access to resources Recommend Favorite